OCUL Projected Dividend Yield

Ocular Therapeutix Inc ( NASDAQ : OCUL )

Ocular Therapeutix, Inc. is a biopharmaceutical company engaged in the development and commercialization therapies for eye conditions, including wet age-related macular degeneration (wet AMD), diabetic retinopathy and other ocular diseases. Co.'s commercial product, DEXTENZA, treats ocular inflammation and pain following eye surgery and ocular itching due to allergic conjunctivitis. Co. is also developing OTX-DED for short-term dry eye disease treatment and OTX-CSI for chronic dry eye disease management. It is conducting a Phase III trial for AXPAXLI to treat wet AMD and are also advancing PAXTRAVA in Phase III clinical development for primary open-angle glaucoma or ocular hypertension.

21 YEAR PERFORMANCE RESULTS

OCUL Dividend History Detail
OCUL Dividend News
OCUL Competitors News
# of Shares: 0 Closing Price: 10.76 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
2026 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor